Breast
Featured Articles
(Rutgers/CINJ) Dec 14, 2017 - Predicting how patients will respond to anti-cancer therapies can be vital in informing clinical decisions and improving treatment outcome.
Read Article
(Endpoints News) Dec 13, 2017 - Pharma giant Daiichi Sankyo is bailing on its collaboration with Nektar Therapeutics — and demanding a $12.5 million refund — following the smaller company’s failure to get its cancer drug Onzeald approved in Europe.
Read Article
Latest Articles
December 13, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 12, 2017
December 12, 2017
View More
News Commentary
Editor Image
15 Feb, 2017 | by William Harwin MD
At Florida Cancer Specialists we have been using DigniCap for several months at...
View Comment
Editor Image
02 Mar, 2017 | by Dean Gesme, MD
Aphinity is expected to be practice changing for Her2 positive early breast...
View Comment
View More
OBR Green
There are no Breast OBR Green articles.
OBR Blog
By Jay Grisolano, PhD and Stephanie Ritz, PhD Approximately a quarter of breast cancer patients are classified as... Read more
June 05, 2017
By Liseth Parra, Ph.D., and Stephanie Hawthorne, Ph.D.   A very exciting therapeutic area that has been constantly... Read more
June 05, 2017